Rituximab and Gemcitabine for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT00216164 · TERMINATED
Trial details
- NCT number
- NCT00216164
- Sponsor
- Hoosier Cancer Research Network
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-03-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.